WEBSITE BSE:542933 NSE : UNIVPHOTO 09 Dec, 13:07
Market Cap ₹411 Cr.
Stock P/E -2.1
P/B 0.4
Current Price ₹375.1
Book Value ₹ 986.2
Face Value 10
52W High ₹484.4
Dividend Yield 0%
52W Low ₹ 318
Universus Photo Imagings Ltd manufactures, sells, and trades in photographic and other imaging products. It gives photographic papers, NTR films, roll films, clinical X-ray films, and many others. The agency changed into formerly called Jindal Photo Imaging Ltd and changed its name to Universus Photo Imagings Ltd in December 2019. Universus Photo Imagings Ltd was integrated in 2011 and is primarily based in New Delhi, India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 13 | 12 | 10 | 8 | 8 | 8 | 7 | 10 | 9 | 6 |
Other Income | 3 | 7 | 24 | 8 | 10 | 6 | 16 | 6 | 7 | 20 |
Total Income | 16 | 19 | 34 | 16 | 18 | 14 | 23 | 15 | 16 | 26 |
Total Expenditure | 13 | 16 | 9 | 7 | 7 | 7 | 7 | 9 | 9 | 7 |
Operating Profit | 3 | 3 | 25 | 9 | 11 | 7 | 16 | 6 | 8 | 19 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 3 | 3 | 25 | 9 | 11 | 7 | 16 | 6 | 8 | 19 |
Provision for Tax | -2 | 2 | 3 | 2 | 3 | 2 | 4 | 1 | 2 | 5 |
Profit After Tax | 5 | 1 | 22 | 7 | 8 | 5 | 12 | 5 | 6 | 14 |
Adjustments | 27 | -14 | -50 | -42 | -44 | -53 | -82 | -49 | -18 | 195 |
Profit After Adjustments | 32 | -13 | -28 | -35 | -35 | -48 | -69 | -43 | -12 | 209 |
Adjusted Earnings Per Share | 29 | -12.1 | -25.6 | -31.9 | -32.1 | -44 | -63.4 | -39.7 | -10.9 | 190.9 |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|
Net Sales | 0 | 62 | 47 | 56 | 43 | 32 | 32 |
Other Income | 0 | 11 | 11 | 472 | 34 | 38 | 49 |
Total Income | 0 | 74 | 58 | 529 | 78 | 70 | 80 |
Total Expenditure | 0 | 53 | 39 | 46 | 37 | 30 | 32 |
Operating Profit | -0 | 21 | 19 | 483 | 40 | 40 | 49 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | -0 | 20 | 39 | 597 | -40 | -187 | 49 |
Provision for Tax | 0 | 4 | 5 | 82 | 5 | 9 | 12 |
Profit After Tax | -0 | 16 | 34 | 514 | -44 | -196 | 37 |
Adjustments | 0 | 28 | 0 | 0 | 0 | 0 | 46 |
Profit After Adjustments | -0 | 44 | 34 | 514 | -44 | -196 | 85 |
Adjusted Earnings Per Share | 0 | 40.1 | 31.3 | 469.9 | -40.6 | -179.4 | 76.9 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -26% | -12% | 0% | 0% |
Operating Profit CAGR | 0% | 28% | 0% | 0% |
PAT CAGR | 0% | NAN% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -6% | -21% | NA% | NA% |
ROE Average | -21% | 7% | 6% | 5% |
ROCE Average | -20% | 10% | 8% | 6% |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|
Shareholder's Funds | -0 | 1212 | 1107 | 1073 | 1048 | 864 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 9 | 10 | 9 | 8 | 14 |
Total Current Liabilities | 0 | 4 | 2 | 8 | 2 | 2 |
Total Liabilities | 0 | 1224 | 1120 | 1090 | 1058 | 880 |
Fixed Assets | 0 | 10 | 9 | 5 | 4 | 4 |
Other Non-Current Assets | 0 | 1065 | 946 | 512 | 463 | 248 |
Total Current Assets | 0 | 150 | 164 | 574 | 591 | 628 |
Total Assets | 0 | 1224 | 1120 | 1090 | 1058 | 880 |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 27 | 0 | 0 | 0 |
Cash Flow from Operating Activities | -0 | 1185 | 56 | -60 | -8 | 4 |
Cash Flow from Investing Activities | 0 | -1168 | -82 | 59 | 19 | -3 |
Cash Flow from Financing Activities | -0 | 11 | -0 | -0 | -11 | -0 |
Net Cash Inflow / Outflow | -0 | 27 | -27 | -0 | -0 | 1 |
Closing Cash & Cash Equivalent | 0 | 27 | 0 | 0 | 0 | 1 |
# | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 0 | 40.1 | 31.29 | 469.87 | -40.62 | -179.37 |
CEPS(Rs) | -1.62 | 15.01 | 31.79 | 470.27 | -40.38 | -179.17 |
DPS(Rs) | 0 | 0 | 0 | 0 | 10 | 0 |
Book NAV/Share(Rs) | 0 | 1106.87 | 1011.26 | 979.95 | 957.36 | 788.91 |
Core EBITDA Margin(%) | 0 | 15.43 | 16.79 | 18.65 | 13.76 | 8.01 |
EBIT Margin(%) | 0 | 32.27 | 82.57 | 1062.7 | -91.42 | -576.22 |
Pre Tax Margin(%) | 0 | 32.25 | 82.56 | 1062.69 | -91.42 | -576.22 |
PAT Margin (%) | 0 | 25.2 | 72.94 | 915.84 | -102.9 | -605.12 |
Cash Profit Margin (%) | 0 | 26.33 | 74.1 | 916.61 | -102.28 | -604.45 |
ROA(%) | -147.27 | 2.57 | 2.92 | 46.56 | -4.14 | -20.27 |
ROE(%) | 0 | 2.6 | 2.95 | 47.19 | -4.19 | -20.54 |
ROCE(%) | 0 | 3.32 | 3.34 | 54.76 | -3.73 | -19.56 |
Receivable days | 0 | 14.72 | 15.73 | 13.46 | 17.47 | 20.45 |
Inventory Days | 0 | 45.14 | 52.3 | 65.64 | 112.33 | 106.17 |
Payable days | 0 | 8.07 | 17.95 | 12.29 | 13.19 | 10.42 |
PER(x) | 0 | 1.3 | 5.05 | 1.17 | 0 | 0 |
Price/Book(x) | 0 | 0.05 | 0.16 | 0.56 | 0.38 | 0.42 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 2.76 | 0 |
EV/Net Sales(x) | 0 | 0.48 | 3.67 | 10.7 | 9.17 | 11.15 |
EV/Core EBITDA(x) | -7.86 | 1.44 | 8.93 | 1.24 | 9.84 | 8.94 |
Net Sales Growth(%) | 0 | 0 | -24.76 | 19.6 | -23.05 | -24.92 |
EBIT Growth(%) | 0 | 0 | 92.53 | 1439.3 | -106.62 | -373.23 |
PAT Growth(%) | 0 | 0 | 117.79 | 1401.55 | -108.65 | -341.55 |
EPS Growth(%) | 0 | 0 | -21.97 | 1401.55 | -108.65 | -341.55 |
Debt/Equity(x) | -0.68 | 0 | 0 | 0 | 0 | 0 |
Current Ratio(x) | 0.27 | 41.19 | 71.78 | 69.54 | 254.1 | 374.92 |
Quick Ratio(x) | 0.27 | 39.07 | 69.28 | 67.78 | 248.87 | 370.9 |
Interest Cover(x) | -8 | 2797 | 0 | 0 | 0 | 0 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 74.55 | 74.55 | 74.55 | 74.55 | 74.55 | 74.55 | 74.55 | 74.55 | 74.55 | 74.55 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 25.45 | 25.45 | 25.45 | 25.45 | 25.45 | 25.45 | 25.45 | 25.45 | 25.45 | 25.45 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About